Eric J. Huselton, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-1042

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Faculty Appointments

Assistant Professor - Department of Medicine , Hematology/Oncology (SMD)

Patient Care Settings

Cancer, Hospital Medicine

Biography

Dr. Eric Huselton received his medical degree from SUNY Downstate College of Medicine in 2012. He completed an Internal Medicine Residency Training Program and a Hematology/Oncology Fellowship at Washington University in Saint Louis/Bames Jewish Hospital in 2015 and 2018, respectively. Dr. Huselton is certified by the American Board of Internal Medicine.

Dr. Huselton is an Assistant Professor in the Division of Hematology and Oncology at the University of Rochester School of Medicine and Dentistry.

Dr. Huselton's special interests include allogenic hematopoietic cell transplant, haploidentical hematopoietic cell transplant, AML, MDS and hematologic malignancies. He aims to provide the best care by incorporating new treatments based on the most recent data, including clinical trials, targeted therapies, immunotherapy and cellular therapies. Dr. Huselton's hobbies include sailing, hiking and cooking.

Credentials

Education

2012
MD | SUNY Downstate Medical Center College of Nursing

Post-doctoral Training & Residency

07/01/2015 - 06/30/2018
Fellowship in Hematology & Oncology at Washington University Dept of Ophthalmology-GME

07/01/2013 - 06/30/2015
Residency in Internal Medicine at Washington University in St. Louis

06/01/2012 - 06/30/2013
Internship in Internal Medicine at Washington University in St. Louis

VIEW ALL

Awards

2019 - 2022
Wilmot Fellowship Award
Sponsor: Wilmot Cancer Institute
Location: Rochester, NY

2016
Travel Award, Society of Hematologic Oncology

2012
Harold A. Lyons Award for Excellence in Clinical Medicine

2011
Alpha Omega Alpha
Location: SUNY Downstate College of Medicine

2009
Downstate Alumni Summer Research Fellow

VIEW ALL

Clinical Trials

Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance

Lead Researcher: Eric J Huselton

The investigators will prospectively determine whether the relapse-free and overall survival in patients who have cleared their leukemia-associated mutations treated with standard consolidation chemotherapy is superior to what is expected based on historical controls. The investigators will also prospectively determine the relapse-free and overall survival of patients who have not cleared their mutations. Because the relapse rate of patients with persistent mutations is expected to be high, treatment with either standard of care consolidation therapy alone or alloSCT will be permitted, at the discretion of the treating physician.

View Study Details

Publications

Journal Articles

2/17/2023
Rashidi A, Huselton EJ, Stefanski HE, DeFor TE, Shanley R, Choi J, DiPersio JF, Juckett M, Miller JS, Weisdorf DJ, Schroeder MA. "A multicenter phase 2 clinical trial of 10-day decitabine, dose-escalated donor lymphocyte infusion, and ruxolitinib for relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic cell transplantation." Transplantation and cellular therapy.. 2023 Feb 17; Epub 2023 Feb 17.

1/13/2023
Holloway MR, Fountaine T, Henrichs K, Feeney T, Andolina J, O'Dwyer K, Liesveld J, Blumberg N, Huselton E. "Association of crystalloid fluid infusion with intravascular hemolysis and organ dysfunction in hematopoietic stem cell transplant patients." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.. 2023 Jan 13; :103641. Epub 2023 Jan 13.

12/19/2022
LoCastro M, Sanapala C, Wang Y, Jensen-Battaglia M, Wittink M, Norton S, Klepin HD, Richardson DR, Mendler JH, Liesveld J, Huselton E, O'Dwyer K, Cortes AM, Rodriguez C, Dale W, Loh KP. "Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study." Cancer medicine. 2022 Dec 19; Epub 2022 Dec 19.

VIEW ALL PUBLICATIONS